BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22687416)

  • 41. Hepatobiliary transport of YM466, a novel factor Xa inhibitor, in rats.
    Mano Y; Usui T; Kamimura H
    Eur J Drug Metab Pharmacokinet; 2006; 31(2):117-21. PubMed ID: 16898080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer.
    Yamada T; Arai T; Nagino M; Oda K; Shoda J; Suzuki H; Sugiyama Y; Nimura Y
    Langenbecks Arch Surg; 2005 Sep; 390(5):421-9. PubMed ID: 15965653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of taurolithocholate-3-sulphate on biliary excretion of sulphobromophthalein and dibromosulphophthalein in the Eisai hyperbilirubinaemic rat.
    Takikawa H; Sano N; Sato A; Yamanaka M
    J Gastroenterol Hepatol; 1997 Jul; 12(7):528-31. PubMed ID: 9257245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Partial characterization of mechanism(s) by which sulphobromophthalein reduces biliary lipid secretion.
    Yamashita G; Tazuma S; Horikawa K; Aihara N; Ochi H; Teramen K; Yamashita Y; Sasaki M; Ohya T; Kajiyama G
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):173-7. PubMed ID: 8471036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Azithromycin reverses anticancer drug resistance and modifies hepatobiliary excretion of doxorubicin in rats.
    Asakura E; Nakayama H; Sugie M; Zhao YL; Nadai M; Kitaichi K; Shimizu A; Miyoshi M; Takagi K; Takagi K; Hasegawa T
    Eur J Pharmacol; 2004 Jan; 484(2-3):333-9. PubMed ID: 14744620
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats.
    Gotoh Y; Suzuki H; Kinoshita S; Hirohashi T; Kato Y; Sugiyama Y
    J Pharmacol Exp Ther; 2000 Jan; 292(1):433-9. PubMed ID: 10604980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatobiliary excretion of acetaminophen glutathione conjugate and its derivatives in transport-deficient (TR-) hyperbilirubinemic rats.
    Chen C; Hennig GE; Manautou JE
    Drug Metab Dispos; 2003 Jun; 31(6):798-804. PubMed ID: 12756215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Involvement of multidrug resistance-associated protein 2 (ABCC2/Mrp2) in biliary excretion of micafungin in rats.
    Abe F; Ueyama J; Kimata A; Kato M; Hayashi T; Nadai M; Saito H; Takeyama N; Noguchi H; Hasegawa T
    Life Sci; 2008 Aug; 83(7-8):229-35. PubMed ID: 18638490
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Curcumin in Hepatobiliary Disease: Pharmacotherapeutic Properties and Emerging Potential Clinical Applications.
    Hu RW; Carey EJ; Lindor KD; Tabibian JH
    Ann Hepatol; 2017 November-December,; 16(6):835-841. PubMed ID: 29055920
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanism of hepatobiliary transport of a novel thromboxane A2 receptor antagonist, [2-(4-chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335), and its xenobiotic taurine conjugate (Z-335-Tau) in rats.
    Kawabata Y; Nakamura H; Kamada E; Furuta S; Shinozaki Y; Kurimoto T; Nishigaki R
    J Pharm Sci; 2003 Jan; 92(1):67-76. PubMed ID: 12486683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury.
    Li X; Zhong K; Guo Z; Zhong D; Chen X
    Drug Metab Dispos; 2015 Nov; 43(11):1751-9. PubMed ID: 26276582
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-Dose Metformin May Increase the Concentration of Atorvastatin in the Liver by Inhibition of Multidrug Resistance-Associated Protein 2.
    Shin E; Shin N; Oh JH; Lee YJ
    J Pharm Sci; 2017 Apr; 106(4):961-967. PubMed ID: 27964938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of penicillin G on the biliary excretion of cholephilic compounds in rats.
    Fukami M; Tanka A; Takikawa H
    J Hepatobiliary Pancreat Sci; 2011 Sep; 18(5):684-8. PubMed ID: 21431887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR).
    Ishizuka H; Konno K; Naganuma H; Sasahara K; Kawahara Y; Niinuma K; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1304-11. PubMed ID: 9067317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bisphenol a glucuronidation and excretion in liver of pregnant and nonpregnant female rats.
    Inoue H; Tsuruta A; Kudo S; Ishii T; Fukushima Y; Iwano H; Yokota H; Kato S
    Drug Metab Dispos; 2005 Jan; 33(1):55-9. PubMed ID: 15466492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. OATP1B1, OATP1B3, and mrp2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II blocker.
    Nakagomi-Hagihara R; Nakai D; Kawai K; Yoshigae Y; Tokui T; Abe T; Ikeda T
    Drug Metab Dispos; 2006 May; 34(5):862-9. PubMed ID: 16501004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced folate derivatives are endogenous substrates for cMOAT in rats.
    Kusuhara H; Han YH; Shimoda M; Kokue E; Suzuki H; Sugiyama Y
    Am J Physiol; 1998 Oct; 275(4):G789-96. PubMed ID: 9756510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Involvement of sulfate conjugation and multidrug resistance-associated protein 2 (Mrp2) in sex-related differences in the pharmacokinetics of garenoxacin in rats.
    Hayashi T; Abe F; Kato M; Saito H; Ueyama J; Kondo Y; Imai K; Katoh M; Nadai M; Hasegawa T
    J Infect Chemother; 2011 Feb; 17(1):24-9. PubMed ID: 20676911
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple mechanisms are involved in the biliary excretion of acetaminophen sulfate in the rat: role of Mrp2 and Bcrp1.
    Zamek-Gliszczynski MJ; Hoffmaster KA; Tian X; Zhao R; Polli JW; Humphreys JE; Webster LO; Bridges AS; Kalvass JC; Brouwer KL
    Drug Metab Dispos; 2005 Aug; 33(8):1158-65. PubMed ID: 15860656
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endotoxin does not alter the pharmacokinetics of micafungin, but it impairs biliary excretion of micafungin via multidrug resistance-associated protein 2 (ABCC2/Mrp2) in rats.
    Noda T; Abe F; Ueyama J; Kato M; Katoh M; Nadai M; Saito H; Hasegawa T
    J Infect Chemother; 2011 Apr; 17(2):207-13. PubMed ID: 20835743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.